Junshik Hong

3.0k total citations
179 papers, 2.0k citations indexed

About

Junshik Hong is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Junshik Hong has authored 179 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Hematology, 74 papers in Oncology and 43 papers in Pathology and Forensic Medicine. Recurrent topics in Junshik Hong's work include Acute Myeloid Leukemia Research (44 papers), Lymphoma Diagnosis and Treatment (37 papers) and Hematopoietic Stem Cell Transplantation (20 papers). Junshik Hong is often cited by papers focused on Acute Myeloid Leukemia Research (44 papers), Lymphoma Diagnosis and Treatment (37 papers) and Hematopoietic Stem Cell Transplantation (20 papers). Junshik Hong collaborates with scholars based in South Korea, United States and Puerto Rico. Junshik Hong's co-authors include Jinny Park, Dong Bok Shin, Eun Kyung Cho, Sun Jin Sym, Jae Hoon Lee, Dong‐Yeop Shin, Mi Sun Park, Young Saing Kim, Ju‐Young Jung and Dongbum Suh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Junshik Hong

164 papers receiving 1.9k citations

Peers

Countries citing papers authored by Junshik Hong

Since Specialization

Citations

This map shows the geographic impact of Junshik Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junshik Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junshik Hong more than expected).

Fields of papers citing papers by Junshik Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junshik Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junshik Hong. The network helps show where Junshik Hong may publish in the future.

Co-authorship network of co-authors of Junshik Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Junshik Hong. A scholar is included among the top collaborators of Junshik Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junshik Hong. Junshik Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Prognostic Landscape of <i>TP53</i> Mutations in Hematologic Malignancies	Cancer Research and Treatment	Hyukmin Lee, Moon‐Woo Seong et al.	0
2	Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study	Therapeutic Advances in Hematology	Jee Hyun Kong, Junshik Hong et al.	2
3	Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in JAKi-naïve myelofibrosis.	Journal of Clinical Oncology	John Mascarenhas, Raajit K. Rampal et al.	1
4	Glofitamab combined with poseltinib and lenalidomide for relapsed/refractory diffuse large B cell lymphoma: Interim analysis of GPL study.	Journal of Clinical Oncology	Young‐Il Koh, Ja Min Byun et al.	2
5	Phase II trial of imatinib mesylate in patients with PDGFRA/B ‐negative hypereosinophilic syndrome	British Journal of Haematology	Seokhyeon Kim, Ja Min Byun et al.	2
6	Differences in Clinical Outcomes Between Hydroxyurea-Resistant and -Intolerant Polycythemia Vera Patients	Journal of Korean Medical Science	Sung‐Eun Lee, Junshik Hong et al.	0
7	Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence	Journal of Korean Medical Science	Hun-Gyu Hwang, Ju Hyun Lee et al.	1
8	Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy	Cancer Medicine	Sheehyun Kim, Ja Min Byun et al.	1
9	Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea	Journal of Pain	Mi-Young Park, Dongho Kim et al.	0
10	Effects of tertiary palliative care on the pattern of end‐of‐life care in patients with hematologic malignancies in Korea	European Journal Of Haematology	Jeonghwan Youk, Ja Min Byun et al.	6
11	Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia	Leukemia	Jun Liu, Dong Chan Kim et al.	4
12	Understanding and treatment of cutaneous graft-versus-host-disease	Bone Marrow Transplantation	Junshik Hong, Carrie L. Kitko et al.	5
13	Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients	Journal of Korean Medical Science	Hyun Jin Ahn, Ja Min Byun et al.	3
14	Real-World Outcomes of Ruxolitinib in Patients With Myelofibrosis Focusing on Red Blood Cell Transfusion: A Multicenter Study From the MPN Working Party of the Korean Society of Hematology	Clinical Lymphoma Myeloma & Leukemia	Eun Hee Jung, Junshik Hong et al.	1
15	The immediate impact of physical function and quality of life after hematopoietic stem cell transplantation	Supportive Care in Cancer	Yeji Lee, Inho Kim et al.	1
16	Incidence of Venous Thromboembolism: The 3^rdKorean Nationwide Study	Journal of Korean Medical Science	Hun-Gyu Hwang, Ju Hyun Lee et al.	10
17	Induction of leukemic stem cell differentiation by aryl hydrocarbon receptor agonist and synergy with gilteritinib in FLT3-ITD + acute myeloid leukemia	Leukemia & lymphoma	Dong‐Yeop Shin, Hyungsuk Kim et al.	6
18	High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy	Journal of Clinical Neurology	Soon‐Tae Lee, Ja Min Byun et al.	3
19	Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms	Blood Advances	Junshik Hong, Ju Hyun Lee et al.	22
20	Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)	Journal of Korean Medical Science	Junshik Hong, Soo‐Mee Bang et al.	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact